HCA Healthcare, Inc. HCA NYSE

HCA Healthcare, Inc. (HCA) has shown moderate revenue growth over the past 3 years, expanding from $60.2B to $75.6B (average +7.9%/yr). Net income reached $6.8B, reflecting solid earnings growth at +6.9%/yr on average. The net profit margin is 9%, which is moderate. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 41.5% (moderate), with a -42.9pp trend over the period. With a $112B market cap and MOAT composite score of 72/100, the company has a strong competitive position.

Criteria proven by this page:

• GROWTH (65/100, Pass) — proving strong growth momentum
• PAST (100/100, Pass) — proving consistent earnings. Looking at the full 36-year history, the company was profitable in 35 of 36 years — an excellent long-term track record
• INCOME (45/100, Partial) — the company is profitable but margin is below 15%
• MOAT (72/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 61/100 with 5/7 criteria passed.